Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common stock ("Common Shares")
-
Shares outstanding
-
212,883,456
-
Number of holders
-
177
-
Total 13F shares, excl. options
-
133,836,935
-
Shares change
-
-6,380,907
-
Total reported value, excl. options
-
$1,142,923,387
-
Value change
-
-$55,464,898
-
Put/Call ratio
-
48%
-
Number of buys
-
84
-
Number of sells
-
53
-
Price
-
$8.54
Institutional Holders of OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL) as of Q4 2024
As of 31 Dec 2024 OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL) had 204 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 133,836,935 shares of stock of the company.
Largest 10 holders included Summer Road LLC, Deep Track Capital, LP, VR Adviser, LLC, BlackRock, Inc., VANGUARD GROUP INC, Avoro Capital Advisors LLC, TCG Crossover Management, LLC, CITADEL ADVISORS LLC, Opaleye Management Inc., and ADAGE CAPITAL PARTNERS GP, L.L.C..
This table shows 204 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.